New Treatments For Castration Resistant Prostate Cancer

For the Ask Dr Barken Call In Show on

Tuesday, April 3rd at 6pm Pacific

Time:  Dial 1-877-727-3301 to hear the program.

Question of the week:

  

For castration resistant prostate cancer,

is it better to do Provenge first or Zytiga first?

Video Blog Presentation:

Dr. Barken interviews Dr. Mark Scholz from Prostate

Cancer Oncology.  An important question discussed is 

how to sequence new treatments approved by the FDA.

The related article of the week:

Immunotherapy for Prostate Cancer: Recent Advances,

Lessons Learned, and Areas for Further Research.

Clin Cancer Res; 17(12); 3884–91.  J. L. Gulley and C.G. Drake

This entry was posted in Castration Resistant Prostate Cancer, Immune Therapy, Metastatic Disease, Metastatic Prostate Cancer Disease, Treatments for Prostate Cancer and tagged , , , . Bookmark the permalink.